Liraglutide Attenuates Restenosis After Vascular Injury in Rabbits With Diabetes Via the TGF-ß/Smad3 Signaling Pathway.

Ding, Hai-Xia; Dong, Nan-Xi; Zhou, Chao-Xi; Wang, Fu-Jun; Xing, Na; Ma, Hong-Fang; Hou, Lin

Ding, Hai-Xia; Dong, Nan-Xi; Zhou, Chao-Xi; Wang, Fu-Jun; Xing, Na; Ma, Hong-Fang; Hou, Lin.

Altern Ther Health Med ; 28(6): 22-28, 2022 Sep.

Article in En | MEDLINE | ID: mdl-35751893

Subject(s)

Diabetes Mellitus; Hyperglycemia; Vascular System Injuries; Animals; Antioxidants/pharmacology; Cadherins/pharmacology; Collagen Type I/pharmacology; Constriction, Pathologic; Hyperplasia/drug therapy; Liraglutide/pharmacology; Liraglutide/therapeutic use; Matrix Metalloproteinase 9/metabolism; Matrix Metalloproteinase 9/pharmacology; Proliferating Cell Nuclear Antigen/metabolism; Proliferating Cell Nuclear Antigen/pharmacology; Rabbits; Reactive Oxygen Species/pharmacology; Signal Transduction; Superoxide Dismutase; Transforming Growth Factor beta1/metabolism; Transforming Growth Factor beta1/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Diabetes Mellitus / Vascular System Injuries / Hyperglycemia Type of study: Prognostic_studies Limits: Animals Language: En Journal: Altern Ther Health Med Journal subject: TERAPIAS COMPLEMENTARES Year: 2022 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links